Columbia University
Rethinking Current and Future Treatment Sequence of Moderate to Severe Crohn's Disease: The Emerging Role of Anti-IL23 First Line Therapies
By
Columbia University
FEATURING
Ellen Scherl
By
Columbia University
FEATURING
Ellen Scherl
Comments 1
Login to view comments.
Click here to Login